FROM THE EDITORS
Welcome to the HR+ HER2– Breast Cancer Resource Center! We are pleased to offer a curated selection of current information, practice advancements, literature highlights, and professional resources focused on this clinical area. Our goal is to support advanced practitioners in their critical role of providing evidence-based, high-quality care to patients.
For any questions, comments, suggestions or to request information on a specific topic, please contact us at jadpro-editor@conexiant.com.
![]() |
![]() |
Katie Newlin, RN, MSN, AGPCNP-BC Washington University in St. Louis/Siteman Cancer Center
|
Lisa Salem, MSN, FNP-BC, AOCNP Washington University in St. Louis/Siteman Cancer Center |
Resources
Abemaciclib AE Monitoring
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Intravenous Cancer Treatment Education
Real-world Risk of Recurrence by Nodal Status in Patients with HR+, HER2-, Node-positive, High-Risk Early Breast Cancer
Abemaciclib Clinical Management Guide
News & Literature Highlights